Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia

Clinical trial NCT06068621 · COMPLETED

Trial details

NCT number: NCT06068621
Sponsor: Chinese PLA General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2023-03-01
Primary completion: 2024-05-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.